IGF-1 LR3

Description

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) is a modified analog of naturally occurring IGF-1, engineered with an extended amino acid sequence to increase stability and reduce binding affinity to IGF-binding proteins in research settings. This structural modification results in prolonged activity compared to native IGF-1 in controlled laboratory models.

In human physiology research, IGF-1 is a key signaling molecule involved in cellular growth pathways, protein synthesis regulation, glucose metabolism signaling, and tissue development mechanisms. IGF-1 LR3 has been examined in studies evaluating enhanced receptor interaction and sustained activation of IGF-1 receptor pathways.

Because of its extended half-life profile and reduced binding to IGF-binding proteins, IGF-1 LR3 is frequently included in laboratory research models analyzing cellular proliferation signaling, anabolic pathway regulation, and metabolic response mechanisms.

Each vial contains 1mg of IGF-1 LR3 in a stable lyophilized format. Every batch is HPLC tested to confirm ≥99% purity and ensure research-grade consistency. The sterile vial format maintains stability prior to controlled reconstitution.

Product Specifications:

• Peptide Name: IGF-1 LR3 (Long R3)

• Quantity: 1mg per vial

• Purity: ≥99% (HPLC tested)

• Form: Lyophilized powder in sterile vial

• Appearance: White to off-white lyophilized cake

• Grade: Research Use Only (RUO)

• Storage: Refrigerate after reconstitution

• Certificate of Analysis: Available upon request

⚠ This product is sold strictly for laboratory research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.